Description
D-Seco Paclitaxel is an impurity in the production of paclitaxel.
D-Seco Paclitaxel is an impurity in the production of paclitaxel.
| Purity | ≥90% |
|---|---|
| Formula | C47H53NO15 |
| Formula Wt. | 871.92 |
| Chemical Name | D-Seco Paclitaxel |
| IUPAC Name | 1S,2S,4S,5S,7S,8S,10R,13S)-10-(acetyloxy)-4-[(acetyloxy)methyl]-1,4,5,7-tetrahydroxy-13-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.03,8]pentadec-11-en-2-yl benzoate |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Nicolaou K, Yang Z, Liu J, et al. Total synthesis of taxol. Nature. 1994 Feb 17;367(6464):630-634. PMID: 7906395.
Nicolaou K, Valiulin R. Synthesis and biological evaluation of new paclitaxel analogs and discovery of potent antitumor agents. Org Biomol Chem. 2013 Jul 7;11(25):4154-4163. PMID: 23685867.
Sanchez-Munoz R, Perez-Mata E, Almagro L, et al. A novel hydroxylation step in the taxane biosynthetic pathway: a new approach to paclitaxel production by synthetic biology. Front Bioeng Biotechnol. 2020 May 13;8::410. PMID: 32528936.
Guo B, Kai G, Jin H, et al. Taxol synthesis. African J Biotechnol. 2006 Jan 2;5(1):15-20.
Wang T, Chen Y, Zhuang W, et al. Transcriptome sequencing reveals regulatory mechanisms of taxol synthesis in Taxus wallichiana var. Mairei. Int J Genomics. 2019 May 2;2019:1596895. PMID: 31192250.
Cathepsin inhibitor.
Tripeptide, used to tag proteins.
USP1 inhibitor
NET and SERT inhibitor, NMDA antagonist.
FAK inhibitor.
EGFR inhibitor.
Neuropeptide found in Schistocera gregaria.
Folate analog; thymidylate synthase inhibitor.<...
Tenoxicam impurity
Aromatic acridine derivative, DNA intercalator....
Pyridine; PDE3 inhibitor.
β2-adrenergic agonist.
Steroidal saponin found in Dioscorea.
Peptide fragment of VSV; LDLR agonist.
Triterpene aglycone originally found in Centell...
Diterpene acid found in Pseudolarix kaempferi.<...
AMPK activator, L-type Ca2+ channel and NMDA, h...
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
FIASMA, σ1, RyR2, TrkA/B agonist; SERT, NET in...
AR antagonist.